4//SEC Filing
Zavodnick Todd Erik 4
Accession 0001479290-18-000017
CIK 0001479290other
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 9:12 PM ET
Size
7.1 KB
Accession
0001479290-18-000017
Insider Transaction Report
Form 4
Zavodnick Todd Erik
Chief Commercial Officer
Transactions
- Award
Common Stock
2018-02-08+8,500→ 103,500 total - Award
Employee Stock Option (Right to Buy)
2018-02-08+48,750→ 48,750 totalExercise: $29.15Exp: 2028-02-07→ Common Stock (48,750 underlying)
Footnotes (2)
- [F1]The shares subject to the Restricted Stock award shall vest in three (3) equal annual installments beginning from March 15, 2018, subject to Mr. Zavodnick's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan(the "Plan")) on each vesting date.
- [F2]The shares subject to the stock option shall vest in forty-eight (48) equal monthly installments beginning from February 8, 2018, subject to Mr. Zavodnick's Continuous Service (as defined in the Plan) on each vesting date.
Documents
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeother
Related Parties
1- filerCIK 0001660467
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 9:12 PM ET
- Size
- 7.1 KB